Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.

The population pharmacokinetics of dapsone were examined in human immunodeficiency virus-infected patients receiving dapsone at a dosage of 100 mg twice weekly for the prevention of Pneumocystis carinii pneumonia. Nonlinear mixed-effect modeling was used to determine the best pharmacostatistical mod...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Gatti, G, Merighi, M, Hossein, J, Travaini, S, Casazza, R, Karlsson, M, Cruciani, M, Bassetti, D
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1996
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163614/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9124833/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.12.2743
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!